Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00583635 · ClinicalTrials.gov registry record
Early Pregnancy Antioxidant Supplementation in the Prevention of Preeclampsia
A clinical trial of Preeclampsia and Pregnancy Loss, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- 684
- Enrollment target
- 1
- Study location
NCT00583635: Completed study of Preeclampsia and Pregnancy Loss, sponsored by University of Mississippi Medical Center.
NCT00583635 is a study of Preeclampsia and Pregnancy Loss that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 684 participants, below the 1,112-participant average among 48 other Preeclampsia trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00583635, a study of Preeclampsia and Pregnancy Loss, has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- 684 participants
- Enrollment target
- 1
- Study location
Study Summary
Use of Juice Plus+ food supplements, when initiated in the first trimester and used continuously thereafter, will result in a lower incidence of preeclampsia and pregnancy complications. This is a prospective randomized and blinded placebo controlled study sponsored by NSA, LLC of Memphis, TN.
Conditions Studied
Study Locations (1)
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 684 participants |
| Start Date | 2004-05 |
| Est. Completion | 2011-08 |
What the finished NCT00583635 record still lists
NCT00583635 is an observational study that tracks outcomes without assigning an intervention. The registered 684 participants enrollment target is mid-sized for trials with a published cap, below the 1,112-participant average among 48 other Preeclampsia trials with a reported enrollment target (38% lower).
The record links to 2 conditions, with Preeclampsia appearing as the primary indexed condition, and to 0 interventions.
NCT00583635 reports a single indexed study location in Mississippi.
Frequently Asked Questions
What is clinical trial NCT00583635 about?
NCT00583635 is a clinical study titled "Early Pregnancy Antioxidant Supplementation in the Prevention of Preeclampsia". Use of Juice Plus+ food supplements, when initiated in the first trimester and used continuously thereafter, will result in a lower incidence of preeclampsia and pregnancy complications. This is a prospective randomized and blinded placebo controlled study sponsored by NSA, LLC of Memphis, TN.
What is the current status of trial NCT00583635?
This trial is currently completed. The enrollment target is 684 participants. The study started on 2004-05. Estimated completion is 2011-08.
What conditions does trial NCT00583635 study?
This clinical trial studies the following conditions: Preeclampsia, Pregnancy Loss.
Who is sponsoring clinical trial NCT00583635?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00583635 being conducted?
This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00583635's enrollment target sits among peer trials
684 11th of 48 higher than 38 of 48 other Preeclampsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preeclampsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
RECRUITING · Phase 2
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Daily Aspirin Treatment After Preeclampsia
RECRUITING · Early Phase 1
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Exosome Cargo From Preeclampsia Patients
RECRUITING
-
Prenatal Aspirin and Postpartum Vascular Function
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06795087 · 684 participants
Discharge Medication Use Post-Operatively in GU Cancer Patients
- NCT05099770 · 685 participants · Phase 3
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
- NCT05880199 · 685 participants
BSGM to Evaluate Patients With GI Symptoms
- NCT04333537 · 686 participants · Phase 2
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia